OLD Category: immuno-oncology

Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo

• Najmuddin SUFS, Amin ZM, Tan SW...Chia SL, Yusoff K, Alitheen NB

Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers

• O’Meara T, Marczyk M, Qing T, Yaghoobi V, Blenman K, Cole K, Pelekanou V, Rimm DL, Pusztai L

Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers

• O'Meara T, Marczyk M, Qing T, Yaghoobi V, Blenman K, Cole K, Pelekanou V, Rimm DL, Pusztai L

Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors

• Cervera-Carrascon V et al.,

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

• Motti ML, Minopoli M, Di Carluccio G, Ascierto PA, Carriero MV

CD200 promotes immunosuppression in the pancreatic tumor microenvironment

• Choueiry F, Torok M, Shakya R...Bai XF, Carson III WE, Mace TA

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression

• Alban TJ, Bayik D, Otvos B...Bucala R, Vogelbaum MA, Lathia JD

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

• Marks DK, Gartrell RD, El Asmar M...Connolly E, Saenger Y, Kalinsky K

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors

• Albershardt TC, Leleux J, Parsons AJ, Krull JE, Berglund P, ter Meulen J

Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch

• Tu WJ, McCuaig RD, Tan AHY...Prasanna T, Milburn P, Rao S

Distinct Features of Human Myeloid Cell Cytokine Response Profiles Identify Neutrophil Activation by Cytokines as a Prognostic Feature during Tuberculosis and Cancer

• Devlin JC, Zwack EE, Tang MS, Li Z, Fenyo D, Torres VJ, Ruggles KV, Loke P.

Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma

• Choi KU, Kim A, Kim JY, Kim KH, Hwang C, Lee SJ, Park WY, Jung S, Choi HJ, Kim K.